Literature DB >> 889645

The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.

G G Harrison.   

Abstract

The oral administration of dantrolene for the prophylaxis of malignant hyperthermia (MH) in susceptible swine has been investigated. Complete protection from MH in pigs exposed to the known MH initiating agents, halothane and suxamethonium, was demonstrated.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 889645     DOI： 10.1093/bja/49.4.315

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


  6 in total

Review 1.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

Review 2.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

3.  Severe muscular rigidity at birth: malignant hyperthermia syndrome?

Authors:  K Sewall; R M Flowerdew; P Bromberger
Journal:  Can Anaesth Soc J       Date:  1980-05

4.  Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect).

Authors:  E H Flewellen; T E Nelson; D E Bee
Journal:  Can Anaesth Soc J       Date:  1980-01

5.  Canine malignant hyperthermia: diagnosis of susceptibility in a breeding colony.

Authors:  P J O'brien; P H Cribb; R J White; E D Olfert; J E Steiss
Journal:  Can Vet J       Date:  1983-06       Impact factor: 1.008

6.  Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.

Authors:  C M Friesen; J B Brodsky; M F Dillingham
Journal:  Can Anaesth Soc J       Date:  1979-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.